US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

Integra Lifesciences Holdings Corp

us-stock
To Invest in {{usstockname}}
us-stock
$13.48 0.0251(2.51%) IART at 04 Dec 2025 04:34 PM Medical Devices
Lowest Today 13.385
Highest Today 13.635
Today’s Open 13.41
Prev. Close 13.16
52 Week High 27.13
52 Week Low 10.87
Day’s Range: Low 13.385 High 13.635
52-Week Range: Low 10.87 High 27.13
1 day return -
1 Week return +3.28
1 month return +19.25
3 month return -13.57
6 month return +2.89
1 year return -44.07
3 year return -75.75
5 year return -76.02
10 year return -

Institutional Holdings

BlackRock Inc 13.29

Vanguard Group Inc 9.73

Rubric Capital Management LP 9.44

iShares Core S&P Small-Cap ETF 5.10

Morgan Stanley - Brokerage Accounts 5.05

Fuller & Thaler Asset Management Inc 5.00

Amvescap Plc. 4.54

FullerThaler Behavioral Small-Cap Value 4.46

Undiscovered Managers Behavioral Val L 4.27

Invesco Small Cap Value A 4.02

Dimensional Fund Advisors, Inc. 3.74

State Street Corp 3.63

Paradigm Capital Management, Inc. 2.80

Vanguard Total Stock Mkt Idx Inv 2.63

Goldman Sachs Group Inc 2.21

Geode Capital Management, LLC 2.11

iShares Russell 2000 ETF 2.08

Vanguard Small Cap Index 2.06

Soleus Capital Management, L.P. 1.78

Wellington Management Company LLP 1.70

Charles Schwab Investment Management Inc 1.57

Assenagon Asset Management SA 1.53

Systematic Financial Management LP 1.36

Vanguard Small Cap Value Index Inv 1.33

Neuberger Berman Group LLC 1.10

Millennium Management LLC 1.07

Deerfield Management Co 1.02

VOLORIDGE INVESTMENT MANAGEMENT, LLC 0.96

Vanguard Institutional Extnd Mkt Idx Tr 0.93

Fidelity Small Cap Index 0.86

iShares S&P Small-Cap 600 Value ETF 0.80

Glenmede Small Cap Equity 0.79

Glenmede Small Cap Equity Adv 0.79

iShares Russell 2000 Value ETF 0.76

SPDR® Portfolio S&P 600™ Sm Cap ETF 0.75

DFA US Targeted Value I 0.72

Schwab Fundamental U.S. Small CompanyETF 0.68

Dimensional US Targeted Value ETF 0.57

Paradigm Micro-Cap 0.56

DFA US Small Cap Value I 0.56

Market Status

Strong Buy: 2

Buy: 1

Hold: 5

Sell: 2

Strong Sell: 2

Fundamentals

Market Cap 1025.31 M

PB Ratio 0.9804

PE Ratio 0.0

Enterprise Value 2755.25 M

Total Assets 4037.42 M

Volume 820154

Company Financials

Annual Revenue FY24:1610527000 1610.5M, FY23:1542556000 1542.6M, FY22:1557666000 1557.7M, FY21:1542448000 1542.4M, FY20:1371868000 1371.9M

Annual Profit FY24:1610527000 1610.5M, FY23:908327000 908.3M, FY22:970311000 970.3M, FY21:944640000 944.6M, FY20:851034000 851.0M

Annual Net worth FY24:-6944000 -6.9M, FY23:100853000 100.9M, FY22:180550000 180.6M, FY21:169075000 169.1M, FY20:133892000 133.9M

Quarterly Revenue Q3/2025:402062000 402.1M, Q2/2025:415605000 415.6M, Q1/2025:382653000 382.7M, Q3/2024:380834000 380.8M, Q2/2024:418175000 418.2M

Quarterly Profit Q3/2025:226108000 226.1M, Q2/2025:209332000 209.3M, Q1/2025:194432000 194.4M, Q3/2024:200238000 200.2M, Q2/2024:232470000 232.5M

Quarterly Net worth Q3/2025:-5404000 -5.4M, Q2/2025:-484073000 -484.1M, Q1/2025:-25293000 -25.3M, Q3/2024:-10695000 -10.7M, Q2/2024:-12402000 -12.4M

Fund house & investment objective

Company Information Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Organisation Medical Devices

Employees 4396

Industry Medical Devices

CEO Ms. Mojdeh Poul

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right